The eligibility criteria for most FDA-approved weight loss drugs are as follows: Body mass index (BMI) of 30 or higher (classified as obesity) Body mass index (BMI) of 27 or higher (classified as overweight) with one weight-related health condition, such as hypertension, hyperlipidemia, heart disease, and high blood cholesterol levels
This remains unaddressed by long-term monitoring, and most practitioners recommend that individuals with a history of cancer or active malignancy avoid BPC-157
Most clients experience no side effects, though minor redness, swelling, or slight soreness at the injection site may occur
An injury happensa tweaked shoulder, a strained ligament, maybe just persistent nagging inflammation
Supports hydration and muscle function